167 related articles for article (PubMed ID: 12154113)
21. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Galli A; Mores N; Porzio O; Lauro D; Cardillo C
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E947-52. PubMed ID: 20923961
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the vasodilatory effects of sodium nitroprusside vs. nitroglycerin.
Ranadive SM; Eugene AR; Dillon G; Nicholson WT; Joyner MJ
J Appl Physiol (1985); 2017 Aug; 123(2):402-406. PubMed ID: 28572495
[TBL] [Abstract][Full Text] [Related]
23. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
[TBL] [Abstract][Full Text] [Related]
24. Verapamil-induced vasodilator response is enhanced in essential hypertension.
Bolli P; Hulthén L; Amann FW; Kiowski W; Bühler FR
Gen Pharmacol; 1983; 14(1):185-8. PubMed ID: 6337915
[TBL] [Abstract][Full Text] [Related]
25. Impaired effectiveness of nitric oxide-donors in resistance arteries of patients with arterial hypertension.
Preik M; Kelm M; Feelisch M; Strauer BE
J Hypertens; 1996 Jul; 14(7):903-8. PubMed ID: 8818930
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature.
Kneale BJ; Chowienczyk PJ; Brett SE; Coltart DJ; Ritter JM
J Am Coll Cardiol; 2000 Oct; 36(4):1233-8. PubMed ID: 11028476
[TBL] [Abstract][Full Text] [Related]
27. In vivo characterization of muscarinic receptor subtypes that mediate vasodilatation in patients with essential hypertension.
Bruning TA; Chang PC; Hendriks MG; Vermeij P; Pfaffendorf M; van Zwieten PA
Hypertension; 1995 Jul; 26(1):70-7. PubMed ID: 7607735
[TBL] [Abstract][Full Text] [Related]
28. Effect of captopril and enalapril on endothelial function in hypertensive patients.
Creager MA; Roddy MA
Hypertension; 1994 Oct; 24(4):499-505. PubMed ID: 8088918
[TBL] [Abstract][Full Text] [Related]
29. Endothelial function and common carotid artery wall thickening in patients with essential hypertension.
Ghiadoni L; Taddei S; Virdis A; Sudano I; Di Legge V; Meola M; Di Venanzio L; Salvetti A
Hypertension; 1998 Jul; 32(1):25-32. PubMed ID: 9674633
[TBL] [Abstract][Full Text] [Related]
30. Endothelium-dependent vascular relaxation in patients with type I diabetes.
Smits P; Kapma JA; Jacobs MC; Lutterman J; Thien T
Diabetes; 1993 Jan; 42(1):148-53. PubMed ID: 8420811
[TBL] [Abstract][Full Text] [Related]
31. Ambulatory blood pressure and endothelium-dependent vasodilation in hypertensive patients.
von zur Mühlen B; Millgård J; Sarabi M; Lind L
Blood Press; 2000; 9(2-3):110-5. PubMed ID: 10855733
[TBL] [Abstract][Full Text] [Related]
32. Impaired forearm vasodilatation by acetylcholine in patients with hypertension.
Yoshida M; Imaizumi T; Ando S; Hirooka Y; Harada S; Takeshita A
Heart Vessels; 1991; 6(4):218-23. PubMed ID: 1800481
[TBL] [Abstract][Full Text] [Related]
33. Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.
Duffy SJ; Biegelsen ES; Eberhardt RT; Kahn DF; Kingwell BA; Vita JA
Hypertension; 2005 Oct; 46(4):707-13. PubMed ID: 16172426
[TBL] [Abstract][Full Text] [Related]
34. Effects of norepinephrine on endothelium-dependent vasodilation of forearm resistance vessels.
Rector TS; Bank AJ; De Bruyn VH; Garr MD; Kraemer MD; Kubo SH
Clin Pharmacol Ther; 1993 Mar; 53(3):374-9. PubMed ID: 8453857
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension.
Sherman DL; Keaney JF; Biegelsen ES; Duffy SJ; Coffman JD; Vita JA
Hypertension; 2000 Apr; 35(4):936-41. PubMed ID: 10775565
[TBL] [Abstract][Full Text] [Related]
36. Effects of cardiac transplantation on endothelium-dependent dilation of the peripheral vasculature in congestive heart failure.
Kubo SH; Rector TS; Bank AJ; Tschumperlin LK; Raij L; Brunsvold N; Kraemer MD
Am J Cardiol; 1993 Jan; 71(1):88-93. PubMed ID: 8420242
[TBL] [Abstract][Full Text] [Related]
37. Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension.
Taddei S; Virdis A; Mattei P; Arzilli F; Salvetti A
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S193-5. PubMed ID: 1282967
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
[TBL] [Abstract][Full Text] [Related]
39. Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels.
Eberhardt RT; McMahon L; Duffy SJ; Steinberg MH; Perrine SP; Loscalzo J; Coffman JD; Vita JA
Am J Hematol; 2003 Oct; 74(2):104-11. PubMed ID: 14508796
[TBL] [Abstract][Full Text] [Related]
40. Soluble E-selectin in essential hypertension: a correlate of vascular structural changes.
De Caterina R; Ghiadoni L; Taddei S; Virdis A; Almerigogna F; Basta G; Lazzerini G; Bernini W; Salvetti A
Am J Hypertens; 2001 Mar; 14(3):259-66. PubMed ID: 11281238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
